SCHEMBL5208543

SCHEMBL5208543

O=C(c1ccc(F)cc1)N1CCOCC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.77
PHGDH O43175 2/20 0.69
KDM4E B2RXH2 2/20 0.68
HPGD P15428 3/20 0.65
HSD11B1 P28845 2/20 0.63
MLYCD O95822 1/20 0.62
AKR1C3 P42330 2/20 0.61
TSHR P16473 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MAPK1 P28482 1/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
HTT P42858 1/20 0.59
POLB P06746 1/20 0.58
DNMT1 P26358 1/20 0.58
PTPN7 P35236 1/20 0.58
KMT2A Q03164 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
PKM P14618 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8172365 0.95 EPHX2 (0.71) EPHX2PHGDHKDM4EHPGDHSD11B1
SCHEMBL3644132 0.91 EPHX2 (0.66) EPHX2PHGDHKDM4EHPGDHSD11B1
SCHEMBL10720943 0.90 PHGDH (0.81) EPHX2PHGDHKDM4EHPGDMLYCD
SCHEMBL3946296 0.88 EPHX2 (1.00) EPHX2KDM4EHPGDSMN1; SMN2ALDH1A1
SCHEMBL22305103 0.86 CA12 (0.71) EPHX2KDM4EHPGDHSD11B1L3MBTL1
SCHEMBL6985975 0.86 CA12 (0.71) EPHX2KDM4EHPGDHSD11B1L3MBTL1
SCHEMBL28296651 0.85 HPGD (0.86) EPHX2PHGDHKDM4EHPGDMLYCD
SCHEMBL2199279 0.83 PHGDH (0.71) EPHX2PHGDHKDM4EHPGDMLYCD
SCHEMBL4696938 0.83 HPGD (0.72) EPHX2PHGDHKDM4EHPGDMLYCD
SCHEMBL31334408 0.82 HPGD (0.76) KDM4EHPGDHSD11B1MLYCDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646620-B1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LTD (GB) 2007-08-15 EP disclosed
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands BAILEY JAMES M 2006-11-02 US disclosed
EP-1646620-A1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2006-04-19 EP disclosed
WO-2005014571-A1 SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247227-A1 Substituted piperidines as histamine h3 receptor ligands HRH3, HRH4, HRH1 EPHX2 753/4885PHGDH 1483/4885KDM4E 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.